From a molecular perspective, breast cancer can be classified into four main subtypes, luminal A, luminal B, HER-2-enriched, and triple negative breast cancer (TNBC), with TNBC being the only subtype lacking a dedicated targeted treatment [5,6]. Here, ERBB2 is linked to triple-negative breast carcinoma.